Identification of A-to-I RNA editing profiles and their clinical relevance in lung adenocarcinoma

Wang, C; Huang, MT; Chen, CC; Li, YC; Qin, N; Ma, ZJ; Fan, JY; Gong, LN; Zeng, H; Yang, L; Xu, XF; Zhou, J; Dai, JC; Jin, GF; Hu, ZB; Ma, HX; Tan, FW; Shen, HB

Ma, HX; Shen, HB (通讯作者),Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Epidemiol, Nanjing 211166, Peoples R China.;Ma, HX; Shen, HB (通讯作者),Nanjing Med Univ, Collaborat Innovat Ctr Canc Personized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Peoples R China.;Tan, FW (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.

SCIENCE CHINA-LIFE SCIENCES, 2022; 65 (1): 19

Abstract

Adenosine-to-inosine (A-to-I) RNA editing is a widespread posttranscriptional modification that has been shown to play an important role in tumorigene......

Full Text Link